Introduction {#s1}
============

The mammalian epithelial branching program is a highly dynamic and organized process that leads to the formation of branched networks of tubule structures that terminate in acini with specialized functions. Understanding how epithelial progenitor cells pattern into ducts and acini, and how this is coordinated with ongoing tissue morphogenesis, is one of the central questions in epithelial development. The submandibular gland (SMG) offers a model to study the molecular mechanisms directing epithelial branching morphogenesis and patterning, with distinct synchronized processes of cell proliferation, clefting, differentiation, migration and apoptosis occurring rapidly during embryogenesis ([@bib13]; [@bib24]). The developing SMG epithelium communicates with neighboring mesenchymal, neuronal and endothelial cells to direct reiterative rounds of bud and duct formation that mature into epithelial domains that mediate the production, transportation, and secretion of saliva ([@bib18]; [@bib20]; [@bib21]; [@bib29]; [@bib35]; [@bib41]). Following initial bud formation, it is thought that specification of distinct multipotent progenitor populations give rise to the specialized cell populations that compose the acinar and ductal domains. For example, multi-potent populations of Cytokeratin-5 (Krt5, K5)- and Cytokeratin-14 (Krt14, K14)-positive progenitors are thought to govern the formation of epithelial cells that give rise to the mature ductal structures ([@bib20]; [@bib21]). Although numerous molecular studies have focused on understanding the biology of SMG progenitors, much remains unclear about the intrinsic signals that define their identity and/or control their differentiation.

Recent studies have provided evidence that the transcriptional regulator Yap plays essential roles in stem cell biology and that these roles are essential for the development of branching organs, such as the kidney, lung, pancreas, and mammary gland ([@bib40]). Ectopic expression of *Yap* has been shown to drive the expansion of progenitor populations in several tissues, while conditional deletion of *Yap* in organ-specific stem cells can lead to the inhibition of stem cell specification or the induction of premature differentiation ([@bib23]; [@bib28]; [@bib43]). In particular, the dynamics of Yap localization is implicated in controlling the balance of specification, self-renewal, and differentiation of various stem cell populations. Yap localization is controlled by a multitude of signals that include those mediated by the Hippo pathway ([@bib25]). The Hippo pathway is comprised of a series of kinase-mediated signaling events that result in the phosphorylation and activation of the Lats1 and Lats2 kinases (herein together referred to as Lats1/2). Activated Lats1/2 redundantly direct the phosphorylation of Yap on conserved serine residues, the best characterized of which is S112 in mouse Yap (S127 in human Yap), which restricts the nuclear accumulation and transcriptional activity of Yap. Loss of Lats1/2-mediated regulation of Yap activity leads to defective organ patterning and function ([@bib15], [@bib14]; [@bib31]; [@bib42]), highlighting the importance of Hippo pathway signaling in development.

Here, we used genetic approaches to examine the roles of Hippo-Yap signaling in SMG epithelial development. We found that embryonic deletion of Yap in developing SMGs resulted in severe morphogenesis defects, which notably did not arise from aberrant cell proliferation or apoptosis, but rather from defects in progenitor patterning. We show that Yap is required for the specification of Krt5/Krt14-positive ductal progenitor cells, and that Yap does so, in part, by controlling the expression of the epidermal growth factor family member Epiregulin (Ereg). Treatment of ex vivo cultured SMGs with Ereg was sufficient to expand Krt5/Krt14-positive cells and rescue cell fate specification defects observed in *Yap*-deleted SMGs. Conversely, we found that deletion of the Hippo kinases *Lats1/2* resulted in massive expansion of Krt5/Krt14-positive ductal cells in developing SMG epithelium, and that this phenotype could be blunted by EGFR (ErbB-1) inhibition. These findings demonstrate that Yap is a critical regulator of ductal progenitor cell identity in SMG epithelium and that proper control of Yap localization by Lats1/2 is essential for the maturation of SMG ducts. Our study therefore identifies novel essential effectors of SMG development and provides important insight into early patterning events that are coupled with branching morphogenesis.

Results {#s2}
=======

Nuclear Yap marks distinct populations of developing SMG ductal epithelial cells {#s2-1}
--------------------------------------------------------------------------------

To gain insight into the role(s) of Yap during SMG development we examined the levels and localization of Yap in early branching SMGs using immunofluorescence (IF) microscopy. We closely monitored the distribution of Yap with respect to known markers of early patterning, including Krt14, which labels multipotent progenitors that can give rise to ductal epithelial cells ([@bib20]; [@bib26]) (illustrated in [Figure 1A](#fig1){ref-type="fig"}). We found that Yap was prominently expressed in E13.5 SMG epithelium, and distinct Yap localization differences were apparent in various cell populations of the branching gland. A cell layer at the peripheral edge of each end-bud showed some cells with nuclear Yap localization, whereas all cells immediately adjacent and extending away from the edge of the bud showed cytoplasmic Yap localization ([Figure 1B--C](#fig1){ref-type="fig"}). Yap also showed very prominent nuclear localization in cells transitioning proximally towards the newly developing ductal regions ([Figure 1B--C](#fig1){ref-type="fig"}), overlapping precisely with Krt14-positive ductal progenitors ([Figure 1D](#fig1){ref-type="fig"}).10.7554/eLife.23499.003Figure 1.Nuclear Yap marks distinct populations of developing SMG ductal epithelial cells.(**A**) Illustration depicting the early developing SMG epithelium, with the positioning of relevant multipotent progenitor cells highlighted. (**B**,**C**) Two different magnified IF microscopy images of the bud-duct transition zone showing the localization of Yap (green) in E13.5 mouse SMG epithelium. (**D**) Images from IF microscopy analysis of Yap (green) together with Krt14 (K14, white) shows prominent nuclear Yap in Krt14-positive cells. (**E**) Illustration depicting the maturing stratified SMG ductal epithelium with relevant cell populations highlighted, and a description of our observed localization pattern for Yap. (**F**) Images from IF microscopy analysis of total Yap (green) and phospho-S112 Yap (red) in E15.5 mouse SMGs. In luminal cells, Yap phosphorylation levels are elevated and Yap is excluded from the nucleus, while many basal cells exhibit prominent nuclear Yap localization. (**G**) Images from IF microscopy analysis of E18.5 mouse SMG ducts for Yap (green) and Krt5 (K5, red) showing prominent nuclear Yap localization in a subset of Krt5-positive basal cells and cytoplasmic Yap in Krt5-negative luminal cells. White arrows highlight prominent nuclear Yap localization in the basal cells in (**F**) and (**G**). DAPI was used to mark the nuclei (blue) in all images, and for clarity the basal surface of the epithelium is outlined with a white dotted line. Scale bar = 20 µm. All images represent observations made from a minimum of three biological repeats.**DOI:** [http://dx.doi.org/10.7554/eLife.23499.003](10.7554/eLife.23499.003)

As the ductal epithelium of the SMG starts to mature, cells begin stratifying into luminal and basal layers. Krt5-positive basal-positioned cells possess stem cell activity and are believed to play important roles in adult SMG injury repair ([@bib19]) (illustrated in [Figure 1E](#fig1){ref-type="fig"}). The large majority of maturing ductal epithelial cells in E15.5 and in differentiated E18.5 SMGs exhibited cytoplasmic Yap localization, particularly cells positioned at the luminal layer ([Figure 1F--G](#fig1){ref-type="fig"}). Cytoplasmic Yap localization correlated with increased Serine-112 phosphorylation of Yap (pS112-Yap) ([Figure 1F](#fig1){ref-type="fig"}), which is a site phosphorylated by the Hippo pathway kinases Lats1/2 and promotes cytoplasmic Yap localization ([@bib3]). While few in number, some ductal epithelial cells in E15.5 and E18.5 SMGs exhibited prominent nuclear Yap localization, and these cells were generally positioned in the basal layer of Krt5-positive epithelial cells. However, not all Krt5-positive cells showed nuclear Yap localization, suggesting that nuclear Yap marks a distinct sub-population of cells with this marker or that we captured a snapshot of dynamic Yap localization occurring in these cells ([Figure 1F--G](#fig1){ref-type="fig"}).

Epithelial deletion of Yap results in severe branching defects and impaired ductal domain specification in developing SMGs {#s2-2}
--------------------------------------------------------------------------------------------------------------------------

To assess the importance of Yap in SMG development, we sought to conditionally delete *Yap* in the epithelium of embryonic SMGs. Cre recombinase driven by the promoter of the *Shh* (sonic hedgehog) gene (*Shh*-Cre) ([@bib10]) has previously been used to target the SMG epithelium ([@bib18]), which prompted us to test the efficiency of this model for use in our studies. We started by crossing *Shh*-Cre mice with Rosa26-loxP-STOP-loxP-EYFP mice ([@bib34]), allowing us to mark *Shh*-expressing cells with Enhanced Yellow Fluorescent Protein (EYFP). All *Shh*-Cre-positive/EYFP-positive SMGs that we examined showed robust EYFP signal marking the entire SMG epithelium ([Figure 2A](#fig2){ref-type="fig"}), indicating that the SMG epithelium originates from *Shh*-expressing cells and therefore this Cre model could be used to conditionally target loxP-flanked genes in the SMG epithelium. Accordingly, we found that crossing *Shh*-Cre mice with *Yap*-loxP/loxP mice led to the efficient deletion of *Yap* in the developing SMG epithelium (herein called *Yap*-cnull SMGs) ([Figure 2B](#fig2){ref-type="fig"}), and that this led to striking branching defects. E13.5 *Yap*-cnull SMGs lacked developed clefts and ducts ([Figure 2C--D](#fig2){ref-type="fig"}), and E15.5 *Yap*-cnull glands showed severely disorganized bud-like structures and complete absence of ductal trees ([Figure 2C--E](#fig2){ref-type="fig"}). Interestingly, these phenotypes did not appear to result from global increases in apoptosis ([Figure 2F](#fig2){ref-type="fig"}) or defects in overall epithelial proliferation ([Figure 2G](#fig2){ref-type="fig"}).10.7554/eLife.23499.004Figure 2.Deletion of *Yap* in developing SMG epithelium results in severe branching defects and defective ductal domain patterning.(**A**) Lineage tracing using *Shh*-Cre; ROSA26-lox-STOP-lox-EYFP reporter mouse. E15.5 mouse SMGs of the indicated genotypes were dissected and immediately imaged on an inverted microscope in dark-field for the left panels and for fluorescent EYFP signal in the right panels. In the furthest right panels, the SMGs were compressed under a coverslip to highlight the EYFP-positive epithelial branches. Scale = 200 μm (**B**) Images from IF microscopy imaging of E15.5 *Shh*-Cre-*Yap*-null (Yap-cnull) SMGs for total Yap (green) and phospho-S112 Yap (red) showing efficient deletion of Yap in the SMG epithelium (outlined by a dotted white line). (**C**) Phase-contrast images of E13.5 WT and *Yap*-cnull SMGs showing severe morphogenesis defects in *Yap*-cnull SMGs. Scale = 100 μm. (**D**) Quantitation of bud number from E13.5 WT and *Yap*-cnull SMGs (n = 23). (**E**) Phase-contrast images of E15.5 WT and *Yap*-cnull SMGs indicating a disorganized bud structure and lack of ductal trees in Yap-deficient SMGs. Note that the image from the WT SMG is stitched together from two images. (**F**) Images from IF microscopy analysis of Cleaved-caspase 3 in E15.5 WT and *Yap*-cnull SMGs showing no apparent defect in apoptosis. Note, that the Cleaved-caspase 3 antibody activity was validated in parallel slides containing positive cells. Scale = 20 μm. (**G**) Images from IF microscopy analysis of E15.5 WT and *Yap*-cnull SMGs for Yap (green), Ki-67 (red), or PCNA (white) showing no apparent proliferation defects in Yap-deleted epithelium. Scale = 10 μm. DAPI was used to mark the nuclei (blue). All images represent observations made from a minimum of three biological repeats.**DOI:** [http://dx.doi.org/10.7554/eLife.23499.004](10.7554/eLife.23499.004)

We hypothesized that the morphogenesis defects associated with *Yap* deletion may originate from compromised epithelial patterning, prompting us to examine the distribution of progenitor markers following *Yap* deletion. We first examined fixed E15.5 SMGs, which revealed an almost complete absence of Krt14-positive ductal progenitors ([Figure 3A](#fig3){ref-type="fig"}). To understand the dynamics of progenitor patterning, we isolated E13.5 SMGs from wild-type and *Yap*-cnull embryos and cultured them ex vivo for 24 hr. After 24 hr of explant culture, WT SMGs exhibited extensive branching, with expected robust Krt14 and Krt5 expression in developing ductal epithelial regions, and Krt19 expression marking maturing cells ([Figure 3B--E](#fig3){ref-type="fig"}). *Yap*-cnull SMGs failed to branch after 24 hr of culture and exhibited an almost complete absence of Krt5, Krt14, or Krt19-expressing cells, except for a small segment of the most proximal region ([Figure 3B--E](#fig3){ref-type="fig"}). The lack of these markers suggested that *Yap*-cnull SMGs fail to specify ductal progenitors and consequently ductal epithelium. Parasympathetic nerve innervation plays a crucial role in the growth and regulation of SMG ductal progenitors ([@bib18]; [@bib20]; [@bib26]), which prompted us to examine the distribution of the parasympathetic nerve in *Yap*-cnull SMGs by staining for the nerve marker TuJ1. Despite being present in the *Yap*-cnull SMGs, parasympathetic nerve innervation was diminished and unorganized, suggesting that signaling crosstalk with the nerve may be compromised ([Figure 3F--G](#fig3){ref-type="fig"}). The structural organization of the actin cytoskeleton was also severely disrupted in *Yap*-cnull SMGs ([Figure 3G](#fig3){ref-type="fig"}), indicating defective polarization that is required for proper epithelial maturation. Interestingly, markers associated with the developing bud domains, such as Sox10, were abundant in *Yap*-cnull SMGs ([Figure 4A--C](#fig4){ref-type="fig"}), suggesting that the early development of the bud epithelium is unaffected following the loss of Yap. Taken together, our analyses indicated that the deletion of *Yap* leads to a loss of an early ductal progenitor population, resulting in branching morphogenesis defects.10.7554/eLife.23499.005Figure 3.Yap is required for SMG ductal epithelial patterning.(**A**) IF analysis of Yap (green) and Krt14 (K14, white) in E15.5 WT and *Yap*-cnull SMGs. Scale = 10 µm. (**B--G**) E13.5 WT and *Yap*-cnull SMGs were dissected and cultured for 24 hr ex vivo and then examined by microscopy. (**B**) Phase-contrast images of E13.5 WT and *Yap*-cnull SMGs at the time of dissection and 24 hr after culture. The same SMGs (each column is one SMG) were analyzed by IF for (**C**) Krt14 (K14, magenta), (**D**) Krt5 (K5, green), (**E**) Krt19 (K19, red), (**F**) TuJ1 (yellow), and (**G**) F-actin (white, Phalloidin). DAPI was used to mark the nuclei (blue). Scale = 100 μm. All images represent observations made from a minimum of three biological repeats.**DOI:** [http://dx.doi.org/10.7554/eLife.23499.005](10.7554/eLife.23499.005)10.7554/eLife.23499.006Figure 4.A relative increase in the number of cells expressing the bud marker Sox10 is observed in *Yap*-cnull SMGs.E13.5 WT and *Yap*-cnull SMGs were dissected and cultured for 24 hr ex vivo and then examined by microscopy. (**A**) Phase-contrast images were taken of E13.5 WT and *Yap*-cnull SMGs at the time of dissection and 24 hr after culture. The same SMGs (each column is one SMG) were analyzed by IF for Sox10 (green), TuJ1 (yellow), and F-actin (white). DAPI was used to mark the nuclei (blue). Scale = 100 µm. (**B**) Images from IF microscopy analysis of Sox10 in E13.5 (zoomed in from (**A**)) and E15.5 WT and Yap-cnull SMGs. DAPI was used to mark the nuclei (blue). Scale = 100 μm. (**C**) qPCR analysis of *Sox10* expression in E15.5 WT and Yap-cnull SMGs. The average of three experiments is shown +S.E.M. \[one sample t-test: \*\*p\<0.001\]. All images represent observations made from a minimum of three biological repeats.**DOI:** [http://dx.doi.org/10.7554/eLife.23499.006](10.7554/eLife.23499.006)

Global gene expression analysis identifies Epiregulin as an important signaling effector downstream of Yap that controls ductal progenitor specification {#s2-3}
--------------------------------------------------------------------------------------------------------------------------------------------------------

To gain insight into how Yap directs SMG development, we isolated RNA from three wild type and three *Yap*-cnull E15.5 SMGs (across three litters) and analyzed global gene expression using microarrays. Differential expression analysis using a stringent cutoff (FDRq \<0.01, and fold change of twofold or greater) revealed 105 genes that differed between the *Yap*-cnull and wild-type SMGs, one of which expectedly was *Yap* ([Figure 5---source data 1](#SD1-data){ref-type="supplementary-material"}). Hierarchical clustering of these genes showed that the expression profiles from replicate samples clearly clustered next to each other, with two major clusters of genes showing either reduced or increased expression in *Yap*-cnull SMGs ([Figure 5A](#fig5){ref-type="fig"}). Consistent with IF microscopy, *Krt5* and *Krt14* expression in ductal SMG progenitors was significantly reduced in the absence of Yap, which we further validated by quantitative real-time PCR (qPCR) ([Figure 5B](#fig5){ref-type="fig"}). Several canonical target genes of Yap, such as *Ctgf* and *Cyr61*, were among genes significantly reduced in *Yap*-cnull SMGs, validating that our data reflects Yap-driven gene expression.10.7554/eLife.23499.007Figure 5.Global gene expression analysis of *Yap*-cnull SMGs indicates the aberrant regulation of genes encoding secreted factors and cell fate regulators.(**A**) Cluster analysis of microarray-generated gene expression data from E15.5 WT vs. *Yap*-cnull SMGs showing genes with a \> 2-fold-change and FDR q (filtered) \<0.01. Red depicts increased and blue depicts decreased gene expression. Relevant genes are highlighted in blue including canonical Yap targets (*Ctgf, Cyr61*) as well as relevant SMG epithelial markers (*Krt14, Krt5, and Kit*). (**B**) qPCR analysis of *Yap, Krt14*, and *Krt5* expression in E15.5 WT and *Yap*-cnull SMGs. The average of three SMGs from different litters is shown +S.E.M. (one sample t-test: \*\*\*p\<0.0001). (**C**) DAVID pathway analysis of genes in (**A**) that are reduced and induced in *Yap*-cnull SMGs. (**D**) GSEA of significantly downregulated genes in *Yap*-cnull SMGs shows enrichment for negative regulation of cell differentiation.**DOI:** [http://dx.doi.org/10.7554/eLife.23499.007](10.7554/eLife.23499.007)10.7554/eLife.23499.008Figure 5---source data 1.Genes differentially expressed in Yap-cnull vs WT (FDRq \<0.01; fold change \>2).Differential expression analysis was performed on microarray data obtained from wild type and Yap-cnull E15.5 SMGs. Shown below are genes with a FDRq \< 0.01 that exhibit a fold change of twofold or greater when data from Yap-cnull was compared wild type SMGs. Genes showing reduced expression in the Yap-cnull vs. WT (DOWN) are shown in the left two columns, and genes showing increased expression in the Yap-cnull vs. WT (UP) are shown in the right two columns.**DOI:** [http://dx.doi.org/10.7554/eLife.23499.008](10.7554/eLife.23499.008)10.7554/eLife.23499.009Figure 5---source data 2.Gene Set Enrichment Analysis (GSEA) of genes differentially expressed in Yap-null versus WT SMGs.GSEA (version 2.2.1) was used to identify biological terms, pathways and processes that are coordinately up- or down-regulated within each pairwise comparison. The Entrez Gene identifiers of the human homologs of the genes interrogated by the array were ranked according to the t statistic computed between the Yap-cnull and wild-type groups. Mouse genes with multiple human homologs (or vice versa) were removed prior to ranking, so that the ranked list represents only those human genes that match exactly one mouse gene. This ranked list was then used to perform pre-ranked GSEA analyses (default parameters with random seed 1234) using the Entrez Gene versions of the Hallmark, Biocarta, KEGG, Reactome, Gene Ontology (GO), and transcription factor and microRNA motif gene sets obtained from the Molecular Signatures Database (MSigDB), version 5.0.**DOI:** [http://dx.doi.org/10.7554/eLife.23499.009](10.7554/eLife.23499.009)

Functional annotation clustering of the differentially expressed genes in *Yap*-cnull SMGs using DAVID Bioinformatics Resources ([@bib16]) revealed enrichment of several interesting clusters of genes ([Figure 5C](#fig5){ref-type="fig"}). *Yap*-cnull SMGs were enriched in genes encoding secreted factors, suggesting that Yap plays an important role in altering the microenvironment of SMG epithelium. Enriched among the repressed genes were genes linked to Hippo signaling and those encoding factors with EGF-like domains. Additionally, genes encoding factors associated with the control of stem cell pluripotency were repressed in *Yap*-cnull SMGs. Conversely, genes linked to promoting cell differentiation were induced in *Yap*-cnull SMGs. Similar enrichment for genes encoding secreted factors or stem cell regulators was obtained when differentially expressed genes were examined by Gene Set Enrichment Analysis ([Figure 5---source data 2](#SD2-data){ref-type="supplementary-material"}) ([@bib36]). This analysis revealed a significant negative correlation between genes repressed in *Yap*-cnull SMGs and genes involved in the negative regulation of cell differentiation (i.e. genes normally induced by Yap in a wild type setting positively correlate with genes that prevent cell differentiation) ([Figure 5D](#fig5){ref-type="fig"}). Thus, Yap-mediated transcription has a role in preventing cell differentiation and that genes regulated by Yap likely playing an important role in controlling the specification of multipotent ductal progenitors.

We next interrogated genes differentially expressed in *Yap*-cnull SMGs for growth factors that may potentially be important for altering the microenvironment that directs ductal progenitor specification. Epiregulin (Ereg), an ErbB receptor ligand that has been implicated in cell fate control in other contexts ([@bib8]), was significantly repressed in *Yap*-cnull SMGs, which we confirmed by qPCR ([Figure 6A](#fig6){ref-type="fig"}). To gain insight into the relevance of *Ereg* expression, we examined developing SMGs using RNA in situ analysis, which showed prominent *Ereg* expression in the epithelium of buds, particularly in the developing ductal progenitor regions, as well as in distinct populations of basal cells of the ductal epithelium ([Figure 6B](#fig6){ref-type="fig"}). *Ereg* expression levels, however, were completely lost in *Yap*-cnull SMG ([Figure 6B](#fig6){ref-type="fig"}). Interestingly, co-analysis of *Ereg* levels (RNA in situ) and Yap localization (IF) indicated that cells exhibiting high levels of nuclear Yap also express *Ereg*, suggesting that nuclear Yap activity promotes *Ereg* expression, consistent with our microarray analysis ([Figure 6C](#fig6){ref-type="fig"}).10.7554/eLife.23499.010Figure 6.Yap-induced Epiregulin (Ereg) expression directs ductal progenitor specification.(**A**) qPCR analysis of *Ereg* expression in E15.5 WT vs. *Yap*-cnull SMGs. The average of three SMGs from different litters is shown +S.E.M. \[one sample t-test: \*\*\*p\<0.0001\]. (**B**) In situ hybridization of *Ereg* mRNA in E13.5 WT (duct and bud) and *Yap*-cnull (bud) SMGs. (**C**) Combined in situ hybridization for *Ereg* mRNA (red) and IF for Yap (green) in E13.5 WT SMGs. (**D**,**E**) E13.5 WT and *Yap*-cnull SMGs were dissected and cultured for 24 hr in the presence or absence of 0.5 μg/mL of exogenous Ereg protein and analyzed by phase-contrast and IF for Krt14 (K14, magenta), Krt5 (K5, green), Krt19 (K19, red), TuJ1 (yellow), and F-actin (white, Phalloidin). DAPI was used to mark the nuclei (blue). Scale = 100 μm. (**F**) qPCR analysis of *Yap*, *Krt5*, and *Krt14* expression in the conditions of (**D**) and (**E**). The average of three SMGs from different litters is shown +S.E.M. \[one sample t-test: \*\*\*p\<0.0001\]. All images represent observations made from a minimum of three biological repeats.**DOI:** [http://dx.doi.org/10.7554/eLife.23499.010](10.7554/eLife.23499.010)

To test whether Ereg plays roles in SMG patterning, we treated WT SMG explants with purified exogenous Ereg for 24 hr in ex vivo culture conditions. Ereg treatment led to a morphological thickening and enlargement of the ductal domain that was accompanied by a reduction in the bud domain ([Figure 6D](#fig6){ref-type="fig"}). IF microscopy analysis showed a striking enrichment in Krt5- and Krt14-positive cells, with these cells composing almost the entire SMG epithelium, including distal epithelial regions ([Figure 6D](#fig6){ref-type="fig"}). Comparative staining with Tuj1 showed a more broadly distributed nerve in the Ereg-treated glands, and F-actin cytoskeletal analysis indicated that along with the expansion of ductal progenitors in response to Ereg, the cytoskeletal organization was disrupted ([Figure 6D](#fig6){ref-type="fig"}). Interestingly, treatment of *Yap*-cnull SMG explants with exogenous Ereg partially rescued some of the observed defects. Most notably, we observed the Ereg treatment led to the emergence of Krt5/Krt14-positive cells, with a subset of these cells also expressing Krt19 ([Figure 6E](#fig6){ref-type="fig"}), all of which were normally absent in *Yap*-cnull SMGs. Analysis of the F-actin cytoskeleton of Ereg-treated *Yap*-cnull SMGs suggested a partial rescue in the organization of duct and bud domains, as some regions exhibited ductal-like F-actin organization and buds showed a slight clefting morphology ([Figure 6E](#fig6){ref-type="fig"}). Moreover, slight broadening of nerve innervation was also apparent in the Ereg-treated *Yap*-cnull SMGs. To quantify the effects on cell fate, we performed qPCR analysis on parallel SMG explant cultures, and found that treatment of WT and Yap-cnull SMGs with exogenous Ereg led to increased *Krt5* and *Krt14* expression comparable to control glands without treatment ([Figure 6F](#fig6){ref-type="fig"}). These data indicated that Ereg stimulation of SMG epithelium was capable of rescuing some of the patterning defects observed in *Yap*-cnull epithelium, and that this modestly rescued the associated morphogenesis defects.

To explore the role(s) of endogenous Ereg in SMG epithelial patterning, we transfected E13.5 WT SMGs with either control siRNA or siRNA targeting Ereg, and then cultured the developing SMGs ex vivo for 24 hr. Analysis of RNA isolated from Ereg-depleted SMGs by qPCR indicated a striking deficiency of *Krt5* and *Krt14* expression, accompanied by a small but significant reduction in Yap expression ([Figure 7A](#fig7){ref-type="fig"}). Microscopy analysis of Ereg-depleted SMGs showed branching defects along with a dramatic loss of Krt5-and Krt14-positive cells ([Figure 7B](#fig7){ref-type="fig"}), as well a reduction in cells marked with Krt19 ([Figure 7B](#fig7){ref-type="fig"}). Depletion of Ereg also resulted in diminished nerve innervation and growth ([Figure 7B](#fig7){ref-type="fig"}). Collectively, these observations offer evidence suggesting Ereg is required for the maintenance of a ductal progenitor niche.10.7554/eLife.23499.011Figure 7.Epiregulin knockdown results in the loss of Krt5- and Krt14-positive ductal progenitors accompanied by a disruption of SMG branching.(**A**) qPCR analysis of *Ereg*, *Krt5*, *Krt14*, and *Yap* expression in E13.5 WT SMGs treated with control siRNA or siRNA targeting Ereg. The average of three SMGs from different litters is shown +S.E.M. \[one sample t-test: \*p\<0.01, \*\*p\<0.001, \*\*\*p\<0.0001\]. (**B**) E13.5 WT SMGs were dissected and cultured for 24 hr in the presence of control siRNA or Epiregulin siRNA and analyzed by phase-contrast and IF for Krt14 (K14, magenta), Krt5 (K5, green), Krt19 (K19, red), TuJ1 (yellow), and F-actin (white, Phalloidin). DAPI was used to mark the nuclei (blue). Scale = 100 μm. All images represent observations made from a minimum of three biological repeats.**DOI:** [http://dx.doi.org/10.7554/eLife.23499.011](10.7554/eLife.23499.011)

Loss of Lats1/2-mediated control of Yap in SMG epithelium leads to severe branching morphogenesis defects and uncontrolled ductal epithelial expansion {#s2-4}
------------------------------------------------------------------------------------------------------------------------------------------------------

The Hippo pathway is the primary signaling pathway that controls Yap localization and activity in development and has been implicated in the control of branching morphogenesis ([@bib31]). The Lats1 and Lats2 kinases (Lats1/2) are known to phosphorylate Yap, which restricts nuclear Yap localization and activity ([@bib25]). Given that we observed Yap phosphorylation that correlated with its cytoplasmic localization in maturing SMG ductal epithelium, we next set out to characterize the potential relationship with the Lats1/2 kinases. We started by examining Lats1/2 activity and localization in E15.5 SMGs by IF microscopy using an antibody that recognizes the phosphorylated-active forms of Lats1/2 (p-Lats1/2) ([@bib37]). We found that active Lats1/2 was absent in developing bud epithelium and abundant in mature luminal ductal SMG cells ([Figure 8A](#fig8){ref-type="fig"}). P-Lats1/2 was localized to the apical domain of the majority of luminal ductal cells, correlating with cells that exhibit cytoplasmic Yap localization. We have shown previously that inhibition of Lats2 with siRNA in E13.5 SMG explant cultures gives rise to branching defects ([@bib4]), suggesting that p-Lats1/2 in the ductal epithelium plays an important role. To define how Lats1/2 activity impacts SMG development, we used the *Shh*-Cre recombinase to conditionally delete the *Lats1* and the *Lats2* genes in the epithelium of developing mouse SMGs (herein referred to as *Lats1/2*-cnull) ([@bib15]). Deletion of either *Lats1* or *Lats2* alone did not show any observable morphological defects in SMG development (data not shown). However, deletion of both *Lats1* and *Lats2* led to severe morphogenesis defects, with an almost complete lack of branching at early developmental time points ([Figure 8B--D](#fig8){ref-type="fig"}). E13.5 *Lats1/2*-cnull SMGs displayed an enormous augmentation of the ductal domain at the expense of the distal bud, which continued to expand to a very large size in ex vivo cultures. Similarly, E15.5 *Lats1/2*-cnull SMGs exhibited a large ductal structure with a severely enlarged major/primary ductal structure ([Figure 8D](#fig8){ref-type="fig"}). IF microscopy analysis showed that almost all the epithelial cells within *Lats1/2*-cnull SMGs exhibited strong nuclear Yap localization and that pS112-Yap levels were completely absent ([Figure 8E](#fig8){ref-type="fig"}). To investigate the effect of *Lats1/2* deletion on the entire ductal tree, we analyzed E18.5 WT and *Lats1/2*-cnull SMGs for Krt5, Krt14, and Yap by IF microscopy. While WT ducts only express these markers in basal cells, the major ducts in the *Lats1/2*-cnull SMGs were hyperplastic and did not form an observable lumen, with all cells staining positive for Krt5 and Krt14 ([Figure 8F](#fig8){ref-type="fig"}). Minor ducts in the *Lats1/2*-cnull SMGs were markedly larger and did not exhibit stereotypical branching and budding features as compared to the WT ([Figure 8G](#fig8){ref-type="fig"}). The minor ducts in *Lats1/2* SMGs were composed predominantly of Krt5/Krt14-positive cells, while equivalent WT regions showed positive staining in few basal-positioned cells ([Figure 8G](#fig8){ref-type="fig"}). Gene expression analysis of RNA isolated from *Lats1/2*-cnull SMGs confirmed these large increases in *Krt5* and *Krt14* expression ([Figure 8H](#fig8){ref-type="fig"}).10.7554/eLife.23499.012Figure 8.Deletion of Lats1/2 in developing SMG epithelium leads to aberrant nuclear Yap localization and severe branching morphogenesis and patterning defects.(**A**) IF microscopy analysis of E15.5 SMGs for phospho-Lats1/2 (green) and E-cadherin (red), indicating active Lats1/2 in luminal cells of the ductal epithelium. Scale = 10 µm. (**B**) Phase-contrast images of E13.5 WT and *Shh*-Cre-*Lats1/2* null (*Lats1/2*-cnull) SMGs. Scale = 100 μm (**C**) Quantitation of bud number from E13.5 WT and *Lats1/2*-cnull SMGs. n = 21. (**D**) Phase-contrast images of E15.5 WT and *Lats1/2*-cnull SMGs highlighting the severe ductal expansion phenotype. Note that each respective image is stitched together from two images. (**E**) Images from IF microscopy analysis of E15.5 WT and *Lats1/2*-cnull SMGs for Yap (green), phospho-S112 Yap (red), and DAPI (blue). Scale = 10 µm. (**F**) Images from IF microscopy analysis of E15.5 WT and *Lats1/2*-cnull primary/major (1°) ducts for Krt14 (K14, green) and Krt5 (K5, red). Scale = 10 µm. (**G**) Images from IF microscopy analysis of E15.5 WT and *Lats1/2*-cnull minor (2°) ducts for Krt14 (K14, green) and Krt5 (K5, red). Scale = 10 µm. (**H**) qPCR analysis of *Lats1*, *Lats2*, *Krt5*, and *Krt14* expression in E15.5 WT vs. *Lats1/2*-cnull SMGs. The average of three experiments is shown +S.E.M. \[one sample t-test: \*\*p\<0.001; \*\*\*p\<0.0001\]. All images represent observations made from a minimum of three biological repeats.**DOI:** [http://dx.doi.org/10.7554/eLife.23499.012](10.7554/eLife.23499.012)

EGFR inhibition blunts the patterning defects observed in Lats1/2-cnull SMG epithelium {#s2-5}
--------------------------------------------------------------------------------------

Our observations suggested that inappropriate nuclear Yap activation resulting from *Lats1/2* deletion promotes the expansion of Krt5/Krt14-positive ductal SMG progenitors. We therefore examined whether Ereg levels were altered in *Lats1/2*-cnull SMGs and observed very high expression of *Ereg* compared to WT SMGs, as measured by qPCR ([Figure 9A](#fig9){ref-type="fig"}) and RNA in situ hybridization ([Figure 9B](#fig9){ref-type="fig"}). To examine whether the expansion of cells expressing ductal epithelial progenitor markers within *Lats1/2*-cnull SMGs relied on an Ereg-mediated mechanism, we tested the effects of EGFR inhibition in wild type and *Lats1/2*-cnull developing SMGs ex vivo. Wild type SMGs treated with the EGFR inhibitor AG1478 exhibited branching morphogenesis defects, which were consistent with observations from EGFR-deleted mice ([@bib9]; [@bib17]). IF analysis of the EGFR-inhibited SMGs showed diminished patterning of Krt5 and Krt14 cells, reduced levels of mature Krt19 cells, as well as defective organization of the F-actin cytoskeleton and parasympathetic innervation ([Figure 9C](#fig9){ref-type="fig"}), all of which are phenotypes that resembled *Yap*-cnull SMGs. *Lats1/2*-cnull SMGs grown ex vivo for 24 hr showed an expansion of ductal structures composed of Krt5 and Krt14-positive cells, with a remarkable enlargement of the major ductal region ([Figure 9D](#fig9){ref-type="fig"}). *Lats1/2*-cnull glands also exhibited defective nerve innervation and F-actin cytoskeletal organization, indicating severely compromised patterning and extracellular signaling ([Figure 9D](#fig9){ref-type="fig"}). Notably, some cells within *Lats1/2*-cnull SMGs also expressed Krt19, many of which were also positive for Krt5 and Krt14, suggesting that these cells may be in an aberrant primitive state normally not observed in wild type SMGs ([Figure 9D](#fig9){ref-type="fig"}). Treatment of *Lats1/2*-cnull SMGs with the EGFR inhibitor AG1478 led to a loss of Krt5 and Krt14-positive cells, indicating that EGFR activation drives the expansion of these ductal progenitor-like cells ([Figure 9D](#fig9){ref-type="fig"}). Further, gene expression analysis by qPCR validated the observed differences in *Krt5* and *Krt14* expression in our IF microscopy experiments, with AG1478 treatment of either WT and *Lats1/2*-cnull SMGs leading to an almost complete loss of the expression of these ductal progenitor markers ([Figure 9E](#fig9){ref-type="fig"}).10.7554/eLife.23499.013Figure 9.EGFR inhibition blunts the patterning defects observed in *Lats1/2*-cnull SMG epithelium.(**A**) qPCR validation of *Ereg* expression levels in E15.5 WT vs. *Lats1/2*-cnull SMGs. The average of three experiments is shown +S.E.M. \[one sample t-test: \*\*\*p\<0.0001\]. (**B**) In situ hybridization of *Ereg* mRNA in E13.5 WT and *Lats1/2*-cnull SMGs. (**C**,**D**) E13.5 WT and *Lats1/2*-cnull SMGs were dissected and cultured for 24 hr in the presence or absence of 10 μM EGFR inhibitor AG-1478 and analyzed by phase-contrast and IF for Krt14 (K14, magenta), Krt5 (K5, green), Krt19 (K19, red), TuJ1 (yellow), and F-actin (white, Phalloidin). DAPI was used to mark the nuclei (blue). Scale = 100 μm. (**E**) qPCR analysis of *Lats1*, *Lats2*, *Krt14*, and *Krt5* expression in the conditions of (**C**) and (**D**). The average of three experiments is shown +S.E.M. \[one sample t-test: \*\*p\<0.001; \*\*\*p\<0.0001\]. All images represent observations made from a minimum of three biological repeats.**DOI:** [http://dx.doi.org/10.7554/eLife.23499.013](10.7554/eLife.23499.013)

Collectively, our observations suggest that nuclear Yap plays an essential role in the development of ductal epithelial SMG progenitors (see model in [Figure 10](#fig10){ref-type="fig"}) and that Lats1/2-mediated removal of Yap from the nucleus is required for the maturation of ductal structures.10.7554/eLife.23499.014Figure 10.Illustration depicting the roles of Yap in submandibular gland epithelial development.We propose nuclear Yap specifies the identity of ductal progenitors, in part by promoting the expression of Ereg and subsequent activation of EGFR signaling. Activated Lats1/2 in the maturing ductal structures promotes the phosphorylation of Yap, which directs the removal of nuclear Yap to support ductal epithelial differentiation.**DOI:** [http://dx.doi.org/10.7554/eLife.23499.014](10.7554/eLife.23499.014)

Discussion {#s3}
==========

We present data describing an essential role for the Hippo pathway effector Yap in the development of the salivary gland. We show that the deletion of Yap in developing SMG epithelium leads to severe patterning and morphogenesis defects. Our data suggest that these defects arise, in large part, from the loss of nuclear Yap transcriptional activity, which defines signals important for instructing the specification of ductal epithelial progenitors. This conclusion is based on our observations that *Yap*-cnull SMG epithelium fails to develop ductal domains and shows severely reduced numbers of Krt5 and Krt14-positive cells, which are markers that have been associated with ductal progenitors ([@bib20]; [@bib21]). We show that developing SMG epithelium displays distinct localization patterns for Yap in various regions, with nuclear Yap most pronounced in the cells of the developing bud, cells developing into ductal areas, as well as in subpopulations of basal epithelial cells that line the SMG ducts, which interestingly are all regions that exhibit cytoskeletal tension ([@bib11]). In contrast, cytoplasmic Yap is observed in regions associated with luminal differentiation of the ducts, suggesting that the removal of nuclear Yap is required for SMG epithelial differentiation. Consistent with this premise, deletion of the Hippo pathway Lats1/2 kinases in developing SMG epithelium resulted in aberrant nuclear Yap localization and expansion of Krt5 and Krt14-positive cells in regions that normally undergo ductal maturation.

Hippo pathway-mediated restriction of nuclear Yap activity has classically been associated with the governance of organ size via a growth-restricting mechanism that relies on precise coordination between proliferation and apoptosis ([@bib27]). As such, Yap and upstream Hippo pathway effectors have emerged as influential oncogenes and tumor-suppressors, respectively. As evidenced here, dynamic Hippo signaling during epithelial morphogenesis extends beyond the view that Hippo signaling controls organ size only by directing cell growth. Rather, our observations from *Yap*- and *Lats1/2*-cnull SMGs indicate that Hippo pathway activity is primarily involved in directing a balance in the specification, renewal, and differentiation of ductal progenitors. Similar roles for Hippo pathway-mediated Yap signaling have been described in other branching organs, including the lung, kidney and pancreas ([@bib5]; [@bib6]; [@bib23]; [@bib32]). Interestingly, however, although Yap plays key roles in progenitor control across different organs, the mechanism(s) by which Yap exerts these functions appears to be context-dependent, likely relating to the distinct signaling network that is organized in each respective organ.

The identification of a role for Ereg in SMG patterning and morphogenesis resembles its role in other systems. In the intestine, a Yap-Ereg network that involves neighboring stromal cells is central for promoting epithelial cell survival and inducing a regenerative program ([@bib8]). However, unlike the intestine, our data suggest that in the SMG, Yap promotes the expression of Ereg in the epithelium to sustain a progenitor niche. Accordingly, we observed elevated Ereg expression in the newly forming ductal progenitor regions and in distinct regions of basal ductal epithelium, precisely the sites with the highest levels of nuclear Yap. We further found that depletion of Ereg or small molecule-mediated inhibition of EGFR, a major receptor for Ereg, results in epithelial branching and maturation defects that resemble those in Yap-cnull SMGs. These observations paralleled those observed following the deletion of EGFR ([@bib9]; [@bib17]) and are consistent with recent observations that heparin binding-EGF treatment of SMGs can promote the expansion of Krt5 progenitors ([@bib20]). Importantly, we show that ex vivo treatment of developing SMG organ cultures with Ereg expands Krt5 and Krt14-positive cells even in the absence of Yap, indicating that Ereg signaling is sufficient to overcome cell fate defects associated with Yap deletion. Together, these data support a model (illustrated in [Figure 10](#fig10){ref-type="fig"}) in which nuclear Yap-induced Ereg defines a niche of EGFR signaling that is central in promoting the identity of ductal progenitors.

Signals transduced by the acetylcholine (Ach)/muscarinic (M) receptor 1 in the parasympathetic submandibular ganglion have been shown to increase EGFR protein expression and increase the expansion of Krt5 progenitors in the SMG ([@bib20]). Therefore, it is likely that signals emanating from the nerve may crosstalk with Yap, or Yap-regulated signals may communicate with the nerve to control ductal progenitor specification and maturation. Consistent with this idea, we observed diminished and disorganized parasympathetic innervation in both the Yap-cnull and Lats1/2-cnull SMGs. Recent work has shown that Neuregulin1 (Nrg1), a neuregulin family ligand that can activate EGFR, promotes the expression of Wnt ligands that signal to direct parasympathetic innervation ([@bib18]). The Hippo signaling pathway is highly interconnected with the Wnt pathway ([@bib2]; [@bib38]; [@bib15]). Thus, it is tempting to speculate that Yap-nerve signaling crosstalk plays a key role in ductal progenitor patterning and may be linked to signals that direct epithelial branching.

Our observations implicate the dynamics of Yap localization in the control of ductal epithelial maturation. Several studies have shown that the developing ductal epithelium acquires specialized polarity cues as it matures. Given that polarity cues are tightly integrated with the control of Yap localization and activity ([@bib37]; [@bib39]), it is likely that epithelial polarity-mediated regulation of Yap directs the differentiation of the ductal epithelium. Indeed, recent work in the developing lung epithelium shows that polarity-regulating proteins, such as the Crumbs transmembrane proteins that direct apical domain specification, promote interactions between the Lats1/2 kinases and Yap ([@bib37]). The dynamics of these polarity proteins, which may be controlled by the mechanical microenvironment, direct the localization of Yap and control cell differentiation. For example, basal stem cell cells in the lung epithelium lack aspects of epithelial polarity and exhibit high levels of nuclear Yap that promotes the basal stem cell identity ([@bib37]; [@bib43]).

Notably, we observed a subset of basal epithelial cells in maturing SMG ducts with prominent nuclear Yap localization. These basal cells, a subset of which are marked by Krt5 in adult SMGs, are thought to possess stem cell activity that can repair adult SMG epithelium upon damage ([@bib19]). Therefore, nuclear Yap may contribute to the identity of these stem cells as it does in other organs, such as the skin and the lung ([@bib33]; [@bib37]; [@bib43]). However, nuclear Yap in the ductal basal cells did not perfectly correlate with Krt5 expression, suggesting that the Krt5-positive population is composed of distinct subpopulations, as proposed previously ([@bib22]), or that Yap localization is dynamic in these cells and our observations captured only a snapshot. Our in situ analysis of *Ereg* expression in maturing ducts also suggested that only a sub-population of basal ductal cells express *Ereg*. Thus, it is possible that a Yap-Ereg signaling niche specifies a unique basal progenitor identity. Such a progenitor niche may be dysregulated in salivary gland carcinomas, as Krt5-positive populations are frequently amplified in these tumors. Many studies have implicated Yap as a pro-tumorigenic factor ([@bib12]), and thus knowledge into the developmental mechanisms, such as that provided by our study, may offer insight into the etiology of salivary gland diseases. One such disease may be Sjogren's Syndrome, a debilitating autoimmune disease that affects salivary secretion, as aberrant Yap localization has been observed in the salivary gland epithelium of patients ([@bib4]). Similarly, Krt5-expressing cell populations have been observed to be expanded in Sjogren's Syndrome epithelium ([@bib7]). Thus, dysregulated Yap-mediated cell fate control may be linked to this diseased state.

In summary, our observations indicate that Yap is required for directing ductal SMG epithelial progenitor patterning, with nuclear Yap inducing the expression of Ereg, which drives signals for the specification of ductal epithelial progenitors; removal of Yap from the nucleus is therefore a requirement for the maturation of ductal structures. Importantly, our work highlights similarities in Yap signaling with other branching organs while also uncovering significant differences. Thus, given the importance of Yap signaling in organ development and disease, understanding this context is an important challenge for the future.

Materials and methods {#s4}
=====================

Mice {#s4-1}
----

Developmental studies on wild-type mice were performed using C57BL/6 mice. The *Yap*-loxP/loxP mice ([@bib32]) were generously provided by Dr. Jeff Wrana (LTRI, Toronto, CN) in an ICR/S129 mixed background and bred with C57BL/6 *Shh*-gfpcre (Jackson Laboratories, \#005622) mice to generate *Yap*-cnull animals. The *Lats1*-loxP/loxP and *Lats2*-loxP/loxP mice ([@bib14]; [@bib15]) were generously provided by Dr. Randy Johnson (MD Anderson, Houston, TX) and bred to the *Shh*-gfpcre mice to generate *Lats1/2*-cnull animals. All animal experiments were done in accordance with protocols approved by the Institutional Animal Care and Use Committee at Boston University.

Ex vivo SMG organ cultures {#s4-2}
--------------------------

SMG explants were cultured as previously described ([@bib35]). Briefly, freshly dissected E13.5 SMGs were plated on nucleopore filters for 24 hr and were either lysed for RNA or fixed for immunostaining. When indicated, explants were treated with DMSO or PBS as a control, 0.5 μg/mL Epiregulin (Fisher; 1068EP050) or 10 μM AG1478 (Sigma; T4182). For Ereg knockdown, freshly dissected E13.5 SMGs were transfected with siRNA targeting murine Ereg (CTCAAGTGCAGATTACAAA) or control siRNA (Qiagen, 1027310) delivered by Lipofectamine RNAiMax transfection reagent (Thermo Scientific, 13778030) and cultured for 24 hr before processing.

Microarray analysis {#s4-3}
-------------------

E15.5 WT and *Yap*-cnull SMGs were dissected and the epithelium was separated from the mesenchyme as described ([@bib30]). RNA was extracted from the epithelium using either the RNeasy kit or the miRNeasy Micro kit (QIAGEN). The amount of isolated RNA was normalized and automated sample amplification and biotin labeling were carried out using the NuGEN Ovation RNA Amplification system V2, Ovation WB reagent and Encore Biotin module according to manufacturer's recommendations using an Arrayplex automated liquid handler (Beckman Coulter). Two micrograms of biotin-labeled sscDNA probe were hybridized to a HT_MG-430_PM Affymetrix Array Plate with modified conditions as previously described ([@bib1]). Washing and staining of the hybridized arrays were completed as described in the GeneChip Expression analysis technical manual for HT plate arrays using the Genechip Array Station (Affymetrix) with modifications as previously described ([@bib1]). The processed GeneChip plate arrays were scanned using a GeneTitan scanner (Affymetrix). Raw CEL files (available at Gene Expression Omnibus (GEO) Series GSE90480) were normalized to produce gene-level expression values using the implementation of the Robust Multiarray Average (RMA) in the *affy* R package (version 1.36.1) and an Entrez-Gene-specific probeset mapping (17.0.0) from the Molecular and Behavioral Neuroscience Institute (Brainarray) at the University of Michigan. Differential expression was assessed using the moderated *t* test implemented in the *limma* R package (version 3.14.4). Correction for multiple hypothesis testing was accomplished using the Benjamini-Hochberg false discovery rate (FDR). Human homologs of mouse genes were identified using HomoloGene (version 68). All microarray analyses were performed using the R environment for statistical computing (version 2.15.1). GSEA (version 2.2.1) was performed in a pre-ranked manner (default parameters with random seed 1234) using a list of Entrez Gene identifiers of the human homologs of the genes interrogated by the array, ranked according to the *t* statistic computed between the Yap-cnull and wild-type groups. Mouse genes with multiple human homologs (or *vice versa*) were removed prior to ranking, so that the ranked list represents only those human genes that match exactly one mouse gene. Biocarta, KEGG, Reactome, Gene Ontology (GO), and transcription factor and microRNA motif gene sets (in human Entrez Gene ID space) were obtained from the Molecular Signatures Database (MSigDB), version 5.0.

qPCR {#s4-4}
----

For quantitative real-time PCR, RNA was extracted using the RNeasy kit or miRNeasy Micro Kit (QIAGEN) and reverse-transcribed using iScript enzymes (BioRad). Reactions were prepared using Fast SYBR Green Master Mix (Applied Biosystems; 4385612) and carried out in a ViiA7 Real-Time PCR System (Applied Biosystems) and analyzed using the ddCT method. Primer sequences are listed in the [Table 1](#tbl1){ref-type="table"}. Statistics were performed using Prism 7 (Graphpad).10.7554/eLife.23499.015Table 1.qPCR primer sequences.**DOI:** [http://dx.doi.org/10.7554/eLife.23499.015](10.7554/eLife.23499.015)TargetDirectionSequenceProduct sizeGAPDHForwardTGTTCCTACCCCCAATGTGT137 bpGAPDHReverseGGTCCTCAGTGTAGCCCAAG137 bpYapForwardAATGTGGACCTTGGCACACT106 bpYapReverseACTCCACGTCCAAGATTTCG106 bpLats1ForwardGCGATGTCTAGCCCATTCTC135 bpLats1ReverseGGTTGTCCCACCAACATTTC135 bpLats2ForwardACAGAGACGCAGCTGAAGGT101 bpLats2ReverseCACAGCTTCGTGATGAGGTC101 bpKrt5ForwardGGAGCAGATCAAGACCCTCA145 bpKrt5ReverseCGGATCCAGGTTCTGCTTTA145 bpKrt14ForwardAGCGGCAAGAGTGAGATTTCT106 bpKrt14ReverseCCTCCAGGTTATTCTCCAGGG106 bpSox10ForwardGACCAGTACCCTCACCTCCA83 bpSox10ReverseCGCTTGTCACTTTCGTTCAG83 bpEregForwardTTCTCATCATAACCGCTGGA102 bpEregReverseCCCCTGAGGTCACTCTCTCA102 bp

Immunofluorescence microscopy {#s4-5}
-----------------------------

Embryonic SMGs were dissected and fixed in 4% PFA (Electron Microscopy Sciences; 15710) for 15 min to an hour and processed for paraffin embedding. Staining was performed using a standard dewaxing and hydration protocol, followed by a microwave-assisted antigen retrieval step using a low-pH buffer (Vector Labs; H-3300). Primary antibodies and dilutions used are described in [Table 2](#tbl2){ref-type="table"}. Secondary antibodies used were conjugated to Alexa Fluor-488,--555, −568,--594, or −647 fluorophores (Life Technologies). Slides were mounted using ProLong Gold Antifade Reagent (Life Technologies; P36930), and images were captured using a confocal microscope system (Carl Zeiss; LSM710) or an inverted epi-fluorescent microscope (Carl Zeiss; Axio Observer.D1).10.7554/eLife.23499.016Table 2.Antibodies used.**DOI:** [http://dx.doi.org/10.7554/eLife.23499.016](10.7554/eLife.23499.016)AntigenSpeciesCompanyCat\#DilutionLot\#YapMouseSanta Cruz1011991/100B2713 and A0512YapRabbitCSTD8H1X1/1001Phospho-YapRabbitCST13008S1/1001 and 2Phospho-LATS1/2RabbitAssay Bio TechA81251/100118125Krt5ChickenBiolegend9059011/300D16CF00791Krt5RabbitBiolegend9055011/300D15LF02531Krt14Mouseabcamab78001/100GR185613-1Krt19RatDSHBTROMA-III-c1/10011/12/2015Sox10GoatSanta Cruz173421/100F0315TuJ1MouseR and D SystemsBAM11951/500HVS0215121Phalloidinn/aAlexa FluorA222871/1000866764Krt8RatDSHBTROMA-1-c1/50012/31/2014Ki-67MouseBD5506091/10067176Ki-67Rabbitabcamab166671/100GR86024-1PCNAMouseCST2586P1/1005Cleaved Caspase 3RabbitCST9661S1/10043

In situ hybridization {#s4-6}
---------------------

In situ hybridization was performed as previously described ([@bib23]) and adapted for paraffin-embedded tissue slides. The DIG-labeled *Ereg* probe ([@bib8]) was generously supplied by Dr. Jeffrey Wrana (Lunenfeld-Tanenbaum Research Institute, Toronto, Canada). For the combined in situ/IF experiments, hybridization was carried out as above, but DIG was detected using an antibody conjugated to HRP (DIG-POD) (Roche), which was then amplified with tyramide (Perkin Elmer), and visualized with streptavidin-594 (Life Technologies). Primary incubation with the Yap antibody was carried out when the DIG-POD antibody was applied, and incubation with the secondary antibody was carried out before tyramide amplification.

Whole-mount immunofluorescence {#s4-7}
------------------------------

Embryonic SMGs were dissected and fixed in 4% PFA as above or with an ice-cold 1:1 acetone/methanol mixture at −20°C for 15 min, depending on the antibodies to be used. In general, TuJ1/Phalloidin worked in PFA while the keratin antibodies worked in acetone/methanol. SMGs were permeabilized in 0.5% Triton-X 100 (American Bioanalytical; AB02025) for 30 min to an hour at 4°C, and blocked in the same mix plus 10% donkey serum (Fisher; 50-588-37) for up to 2 hr at 4°C. Primary and secondary antibody incubations were in the serum mixture, and either at 4°C overnight or 1 hr at room temperature. After both primary and secondary incubations, SMGs were washed extensively in 0.5% Triton-X 100 (at least 3, up to six changes; 10 min each) and post-fixed with 4% PFA for 30 min. Counterstaining was performed using Hoechst for 15 min. SMGs were immediately imaged by placing them on a coverslip. For increased resolution, SMGs were compressed between two coverslips before imaging, and imaged using an epi-fluorescent microscope (Carl Zeiss; Axio Observer.D1).
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\[Editors' note: this article was originally rejected after discussions between the reviewers, but the authors were invited to resubmit after an appeal against the decision.\]

Thank you for submitting your work entitled \"The Hippo pathway effector YAP is an essential regulator of submandibular gland ductal progenitor patterning\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by a Senior Editor. The reviewers have opted to remain anonymous.

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*.

The reviewers found your study interesting and highly relevant to the salivary gland, but felt that it lacks the level of novel insight expected for *eLife*. Additionally, there were concerns about extensive reuse of images (for instance, some images appear in [Figures 2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, [6](#fig6){ref-type="fig"} and [8](#fig8){ref-type="fig"}) and lack of information on the numbers of experiments performed, throughout the manuscript.

Reviewer \#1:

In this manuscript, the authors address the role of Yap and its regulators Lats1 and 2 in development of the submandibular gland (SMG). They show by conditional KO (using *Shh*-Cre) that Yap is needed for normal patterning and morphogenesis of the SMG; deletion of Yap results in loss of ductal structures, both in vivo and in explant culture. To gain insight into the mechanism through which Yap regulates SMG development, they then analysed the transcriptomes of E15.5 WT versus CKO SMG. This indicated Epiregulin as among the genes downregulated in the absence of Yap. Subsequent explant culture experiments showed that Epiregulin could partially compensate for loss of Yap; addition of Epiregulin to the in vitro cultures increased the size of the ductal domain and area expressing Keratins 5, 14 and 19, and from this the authors conclude that Epiregulin expression downstream of Yap regulates expansion of ductal progenitors. The authors then go on to show that regulation of Yap by Lats1 and 2 is required for differentiation of ductal epithelial cells; in the absence of Lats1/2, the primary ductal domain is enlarged and shows nuclear Yap localisation, along with substantially increased Epiregulin expression. By pharmacological inhibition, the authors show that signalling through EGFR (the receptor for Ereg) is required for expansion of the ductal progenitors observed in the absence of Lats1/2. Overall the manuscript is very clearly presented and the data appear to be of a high standard.

Reviewer \#2:

In this manuscript Syzmaniak et al. expands on the known roles of Yap in epithelial tissues and progenitor cell regulation by describing a novel role for YAP in regulating epithelial morphogenesis during embryonic salivary gland development. The authors show that genetic ablation of YAP and its regulators LATS1/2 impair epithelial branching morphogenesis and duct formation as well as maintenance of progenitor cells marked by KRT5 and KRT14. Furthermore, they show using genetic experiments and gene expression profiling that YAP is a positive regulator of the EGFR ligand epiregulin: in the absence of epithelial YAP, epiregulin is lost and that epiregulin may be a regulator of the progenitors, thus linking YAP to EGFR signaling. Using ex vivo cultures of the YAP mutant they are able to show that exogenous epiregulin can rescue progenitor cells (if not morphogenesis) in the remaining epithelium, suggesting that a YAP/epiregulin/EGFR signaling regulates these cells. This is further supported by the Lats1/2 conditional mutants where aberrant nuclear Yap expression drives increased levels of epiregulin and ductal progenitors. The increase in progenitors is abrogated when EGFR signaling is blocked. Together these findings begin to define the role of Hippo pathway signaling in the development of the salivary gland as well as establishing the novel requirement for epiregulin.

Substantive concerns

1\) Although this is the first study showing the effects of ablation or activation of the Hippo pathway on salivary gland development, the Hippo pathway has previously been examined in multiple epithelial organs and these have shown a requirement for this pathway in their development and progenitor cell populations. This study indicates that morphogenesis of the tissue as well as the progenitor populations are also perturbed in this organ but the manuscript falls short of revealing new insights into how YAP regulates morphogenic or stem cell programs. The authors do point out some very interesting phenotypic and cellular outcomes, such as the expanded ducts and polarity defects in the LATS1/2 conditional and reduced bud number in the YAP mutant, but stop short of investigating how these cell/tissue phenotypic outcomes are achieved. Further characterization of these phenotypes is required for publication.

2\) The finding that epiregulin is regulated by Hippo signaling is novel. However, there is little data to support the claim that epiregulin is a regulator of ductal progenitors during gland development. The authors use a gain of function assay in the ex vivo system and show increased progenitor cells in the absence of YAP when treated with exogenous epiregulin. This indicates that epiregulin is sufficient, but it does not show that epiregulin is either necessary or is involved in this process in the wild type tissue. Unfortunately, use of a chemical inhibitor of EGFR in the LATS1/2 mutant cultured ex vivo does not solve this due to non-specificity. It is just as likely that inhibition of EGFR is perturbing HBEGF/EGFR interactions. Knockdown or ablation of epiregulin in the epithelium is needed.

3\) Previous studies in the salivary gland show that parasympathetic nerves regulate KRT5+ progenitor cells (Knox et al., 2010; Knosp et al., 2015). The authors in the current study base their conclusion that parasympathetic nerves are not affected by ablation of YAP or are adversely affected by ablation of LATS1/2 by visual inspection. However, visual inspection at low resolution cannot be used alone to draw the conclusion that the nerves are or are not affected. qPCR analysis of neuronal proteins or neurotransmitters that are suggestive of function or growth is needed to substantiate the claim that nerves are or are not altered. In addition, ablation of the nerves or inhibiting of their function would also indicate that they are not involved in altering progenitor populations in the mutants.

Reviewer \#3:

In this manuscript the authors report observations that advance our understanding of the role and regulation of Yap in the salivary gland. They show that Yap phosphorylation and localization are patterned, with nuclear (active) Yap in ductal progenitor cells, and cytoplasmic (inactive) Yap in differentiating cells. This is consistent with studies in other organs that have reported nuclear Yap in progenitor cells. They assess both loss and gain-of-function phenotypes for Yap, through deletion of a Yap conditional allele, or deletion of the Yap regulators Lats1 and Lats2. Consistent with the expression data, these studies support a key role for Yap in specifying progenitor cell fate, with both loss and gain of Yap activity severely disrupting salivary gland development. The authors also conduct expression studies, which leads them to identify the EGFR ligand Epiregulin as a key mediator of Yap activity in the salivary gland. An unanswered question is how Yap activity is normally controlled in the developing salivary gland, but I think it\'s reasonable to leave this for a future study. Overall I found this an interesting report that advances our understanding of salivary gland development and significantly advances our understanding of how Hippo signaling influences salivary gland development.

\[Editors' note: what now follows is the decision letter sent to the authors in response to their appeal.\]

Thank you for choosing to send your work entitled \"The Hippo pathway effector YAP is an essential regulator of submandibular gland ductal progenitor patterning\" for consideration at eLife. Your letter of appeal has been considered by a Senior Editor and a Reviewing editor, and, based on their evaluation, was then sent to an additional expert reviewer for consideration. Having received and considered this fourth review, we are prepared to consider a revised submission with no guarantees of acceptance.

We request you meet the points discussed in your response to the reviewers' comments as you propose; in particular, we note that genetic evidence supporting the proposed role of Epiregulin will be required for further consideration for publication in *eLife*. This point was also highlighted by the additional reviewer, who felt that SMG-specific Epiregulin knock out in the K14/K5 ductal progenitors and differentiated duct would significantly strengthen the manuscript. The additional reviewer also had a number of minor concerns, which we would like you to address in addition to the points discussed in your point-by-point response:

1\. In the cartoon in [Figure 1E](#fig1){ref-type="fig"}, please also highlight where cytoplasmic versus nuclear YAP is observed. In [Figure 1A](#fig1){ref-type="fig"}, Krt5 is misspelled.

2\. It is not clear what the marker is for the SMGs in [Figure 2A](#fig2){ref-type="fig"}, left and middle panels, please clarify.

3\. In [Figure 6A](#fig6){ref-type="fig"}, if possible please show whether Ereg RNA is expressed in the same cells where Yap is nuclear, since there are good protocols for simultaneously imaging transcripts and protein.

4\. Please provide a higher power image/zoom of the images in [Figure 6E](#fig6){ref-type="fig"}, so that the reader can see if Yap is nuclear throughout the gland.

5\. This reviewer also raised similar points to reviewer 2 regarding some of the images used, and also requested that details of the number of animals/samples assessed for each experiment should be included.

10.7554/eLife.23499.020

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

*Reviewer \#2:*

*\[...\] Substantive concerns*

*1) Although this is the first study showing the effects of ablation or activation of the Hippo pathway on salivary gland development, the Hippo pathway has previously been examined in multiple epithelial organs and these have shown a requirement for this pathway in their development and progenitor cell populations. This study indicates that morphogenesis of the tissue as well as the progenitor populations are also perturbed in this organ but the manuscript falls short of revealing new insights into how YAP regulates morphogenic or stem cell programs.*

We respectively disagree with this assessment from the reviewer. Our study reveals for the first time that Yap signaling is essential for salivary gland epithelial development, and offers novel insight into how Yap is directing the development of this organ. In doing so, we describe (for the first time) an important role for Epiregulin (Ereg) in SMG ductal progenitor patterning. Moreover, our manuscript describes (for the first time) that the Lats1/2 kinases are essential upstream regulators of Yap activity in SMG epithelium, and that loss of Lats1/2 leads to an uncontrolled expansion of Krt5/Krt14 cell populations. Our observations have implications beyond SMG development, as Krt5/Krt14 cell populations are critical for SMG epithelial repair and are often dysregulated in diseases, such as cancer. Therefore, we believe our work offers important novel insight into developmental and disease processes and will be relevant to a broad readership.

*The authors do point out some very interesting phenotypic and cellular outcomes, such as the expanded ducts and polarity defects in the LATS1/2 conditional and reduced bud number in the YAP mutant, but stop short of investigating how these cell/tissue phenotypic outcomes are achieved. Further characterization of these phenotypes is required for publication.*

Our manuscript describes Ereg as an important downstream target of Yap that is required for patterning of Krt5/Krt14 ductal epithelial cells, and notably we show that exposure of Yap-null SMGs to Ereg can partially rescue cell fate defects associated with these mutants. We agree that there is much more to be investigated based on the phenotypes we describe, but given that we characterize an important new mechanism for SMG development that contributes to one of the major defects observed in the Yap- and Lats1/2- knockout models, that being the ductal patterning defects, we argue that our manuscript offers important knowledge that should be published.

*2) The finding that epiregulin is regulated by Hippo signaling is novel. However, there is little data to support the claim that epiregulin is a regulator of ductal progenitors during gland development. The authors use a gain of function assay in the* ex vivo *system and show increased progenitor cells in the absence of YAP when treated with exogenous epiregulin. This indicates that epiregulin is sufficient, but it does not show that epiregulin is either necessary or is involved in this process in the wild type tissue. Unfortunately, use of a chemical inhibitor of EGFR in the LATS1/2 mutant cultured* ex vivo *does not solve this due to non-specificity. It is just as likely that inhibition of EGFR is perturbing HBEGF/EGFR interactions. Knockdown or ablation of epiregulin in the epithelium is needed.*

We have performed the Ereg knockdown experiment suggested by the reviewer, and have found that depletion of Ereg in ex vivo cultured SMGs leads to a dramatic loss of Krt5 and Krt14-positive cells and branching defects, agreeing with our model that Ereg is a key mediator of ductal progenitor specification. This data is shown in our new [Figure 7](#fig7){ref-type="fig"}.

*3) Previous studies in the salivary gland show that parasympathetic nerves regulate KRT5+ progenitor cells (Knox et al., 2010; Knosp et al., 2015). The authors in the current study base their conclusion that parasympathetic nerves are not affected by ablation of YAP or are adversely affected by ablation of LATS1/2 by visual inspection. However, visual inspection at low resolution cannot be used alone to draw the conclusion that the nerves are or are not affected. qPCR analysis of neuronal proteins or neurotransmitters that are suggestive of function or growth is needed to substantiate the claim that nerves are or are not altered. In addition, ablation of the nerves or inhibiting of their function would also indicate that they are not involved in altering progenitor populations in the mutants.*

We have revised how we describe the phenotypes we observe with respect to the parasympathetic nerve in our manuscript to better highlight that the nerves are innervated in Yap-null SMGs, but are not organized in the same pattern as in wild type SMGs. This observation is consistent with the defective patterning we observe in Yap-null these mutants, which we discuss in our manuscript.

\[Editors' note: the author responses to the re-review follow.\]

*\[...\] We request you meet the points discussed in your response to the reviewer\'s comments as you propose; in particular, we note that genetic evidence supporting the proposed role of Epiregulin will be required for further consideration for publication in eLife. This point was also highlighted by the additional reviewer, who felt that SMG-specific Epiregulin knock out in the K14/K5 ductal progenitors and differentiated duct would significantly strengthen the manuscript. The additional reviewer also had a number of minor concerns, which we would like you to address in addition to the points discussed in your point-by-point response:*

*1. In the cartoon in [Figure 1E](#fig1){ref-type="fig"}, please also highlight where cytoplasmic versus nuclear YAP is observed. In [Figure 1A](#fig1){ref-type="fig"}, Krt5 is misspelled.*

As requested, we have updated our illustration in [Figure 1E](#fig1){ref-type="fig"} to highlight our observations with Yap localization. We also describe these observations in the updated figure legend, as well as in the main text.

*2. It is not clear what the marker is for the SMGs in [Figure 2A](#fig2){ref-type="fig"}, left and middle panels, please clarify.*

We have updated [Figure 2A](#fig2){ref-type="fig"} to better describe the images shown.

*3. In [Figure 6A](#fig6){ref-type="fig"}, if possible please show whether Ereg RNA is expressed in the same cells where Yap is nuclear, since there are good protocols for simultaneously imaging transcripts and protein.*

We have performed the experiment proposed by the reviewer, and found that cells expressing Ereg are cells with higher levels of nuclear Yap. We have included this data in our new [Figure 6C](#fig6){ref-type="fig"}.

*4. Please provide a higher power image/zoom of the images in [Figure 6E](#fig6){ref-type="fig"}, so that the reader can see if Yap is nuclear throughout the gland.*

As suggested by the reviewer we have updated the images in original [Figure 6E](#fig6){ref-type="fig"} with new zoomed in images that show predominantly cytoplasmic Yap in WT SMGs and nuclear Yap in *Lats1/2-cnull* SMGs. This data is included in our new [Figure 8E](#fig8){ref-type="fig"}.

*5. This reviewer also raised similar points to reviewer 2 regarding some of the images used, and also requested that details of the number of animals/samples assessed for each experiment should be included.*

We have updated our representative figures along with the figure legends to better describe the numbers of repeats we performed for our experiments. We have also updated and added a description of the statistics we used in the respective figure legends.
